Abstract
Background
The present study was designed to identify the optimal intraoperative radiotherapy (IORT) dose for early breast cancer in Japanese women.
Methods
A phase I study was designed using a scheme of dose-escalation from 19, 20, and 21 Gy at 90% isodose. The primary endpoint was early toxicity. Secondary endpoints were efficacy for a long period and late toxicity. Inclusion criteria were as follows: (1) tumor size <2.5 cm, (2) age >50 years, (3) surgical margin >1 cm, (4) intraoperative pathologically free margins, (5) written informed consent. Exclusion criteria were (1) contraindication to radiation therapy, (2) extensive intraductal component. Partial resection was performed with at least a 1-cm margin around the tumor. Radiation was delivered directly to the mammary gland employing a MOBETRON device. Toxicity was evaluated with the Common Terminology Criteria for Adverse Events (CTCAE), version 3.0.
Results
From December 2007 to September 2008, 9 patients were enrolled in the study. The first three patients received a radiation dose of 19 Gy. Within 3 months toxicity in each case was deep connective tissue fibrosis (grade 1: 2/3, grade 2: 1/3). The next three patients received a dose of 20 Gy and had toxicities of deep connective tissue fibrosis (grade 1: 3/3), hematoma (grade 1: 2/3), infection in the musculoskeletal soft tissue (grade 1: 2/3), and soft tissue necrosis (grade 2: 1/3). The final three patients received a dose of 21 Gy and had toxicities of deep connective tissue fibrosis (grade 1: 2/3), hematoma (grade 1: 1/3), infection in the musculoskeletal soft tissue (grade 1: 1/3), and soft tissue necrosis (grade 2: 2/3).
Conclusions
The IORT treatment was tolerated very well in Japanese women, and we now recommend the dose of 21 Gy.
Similar content being viewed by others
References
Early Breast Cancer Trialists’ Collaborative Group (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet 366:2087–2106
Veronesi U, Cascinelli N, Mariani L et al (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227–1232
Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241
Veronesi U, Marubini E, Mariani L et al (2001) Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 12:997–1003
Veronesi U, Orecchia R, Luini A et al (2001) A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer 37:2178–2183
Luini A, Orecchia R, Gatti G et al (2005) The pilot trial on intraoperative radiotherapy with electrons (ELIOT): update on the results. Breast Cancer Res Treat 93:55–59
Veronesi U, Orecchia R, Luini A et al (2005) Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases. Ann Surg 242:101–106
Intra M, Luini A, Gatti G et al (2006) Surgical technique of intraoperative radiation therapy with electrons (ELIOT) in breast cancer: a lesson learned by over 1000 procedures. Surgery 140:467–471
Oshima Y, Aoyama Y, Shimozato T et al (2009) An experimental attenuation plate to improve dose distribution in intraoperative electron beam radiotherapy for breast cancer. Phys Med Biol 54:3491–3500
Skandarajah AR, Lynch AC et al (2009) The role of intraoperative radiotherapy in solid tumors. Ann Surg Oncol 16:735–744
Park CC, Mitsumori M, Nixon A et al (2000) Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 18:1668–1675
Fisher ER (1997) Lumpectomy margins and much more. Cancer 79:1453–1458
Beal K, McCormick B, Zelefsky MJ et al (2007) Single-fraction intraoperative radiotherapy for breast cancer: early cosmetic results. Int J Radiat Oncol Biol Phys 69:19–24
Kyndi M, Sørensen FB, Knudsen H et al (2008) Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol 26:1419–1426
Nguyen PL, Taghian AG, Katz MS et al (2008) Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 26:2373–2378
Vicini FA, Kestin L, Chen P et al (2003) Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 95:1205–1210
Benitez PR, Keisch ME, Vicini F et al (2007) Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg 194:456–462
Vicini FA, Baglan KL, Kestin LL et al (2001) Accelerated treatment of breast cancer. J Clin Oncol 19:1993–2001
Antonucci JV, Wallace M, Goldstein NS et al (2009) Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up. Int J Radiat Oncol Biol Phys 74:447–452
Holmes DR, Baum M, Joseph D (2007) The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update). Am J Surg 194:507–510
Buchholz TA (2009) Radiation therapy for early-stage breast cancer after breast-conserving surgery. N Engl J Med 360:63–70
Williams CP, Reynolds HL, Delaney CP et al (2008) Clinical results of intraoperative radiation therapy for patients with locally recurrent and advanced tumors having colorectal involvement. Am J Surg 195:405–409
Vaidya JS, Tobias JS, Baum M et al (2004) Intraoperative radiotherapy for breast cancer. Lancet Oncol 5:165–173
Author information
Authors and Affiliations
Corresponding author
Additional information
This article was presented in part at the primary therapy of Early Breast Cancer 11th International Conference, St. Gallen, Switzerland, 11–14, March 2009.
Rights and permissions
About this article
Cite this article
Sawaki, M., Sato, S., Kikumori, T. et al. A Phase I Study of Intraoperative Radiotherapy for Early Breast Cancer in Japan. World J Surg 33, 2587–2592 (2009). https://doi.org/10.1007/s00268-009-0227-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-009-0227-8